Back to search

Article

Leveraging Synergy: The Therapeutic Potential of SN-38 and Immunotherapy in Breast and Prostate Cancer Treatment

2025-09-03

Abstract excerpt

Breast and prostate cancers, two of the most prevalent malignancies worldwide, pose sig-nificant therapeutic challenges due to resistance to conventional treatments and their complex tumor microenvironments. The integration of innovative therapies into current clinical frameworks is essential to improve patient outcomes. SN-38, the active metabolite of irinotecan, has emerged as a potent chemotherapeutic agent wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
743fd5ed-444e-5c37-9afa-54eec5813858
DOI
10.20944/preprints202509.0263.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Leveraging Synergy: The Therapeutic Potential of SN-38 and Immunotherapy in Breast and Prostate Cancer TreatmentDOI 10.20944/preprints202509.0263.v1
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.Semantic proximity
Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase InhibitorsSemantic proximity
Targeted and cytotoxic inhibitors used in the treatment of breast cancerSemantic proximity
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, other than Abscopal Effect: A Systematic ReviewSemantic proximity
Overview of targeted therapies for cancerSemantic proximity
Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung CancerSemantic proximity
Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic ViewpointSemantic proximity
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.Semantic proximity
The future of cancer treatment: combining radiotherapy with immunotherapySemantic proximity
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSemantic proximity
Combining DNA damaging therapeutics with immunotherapy: more haste, less speedSemantic proximity
Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translationSemantic proximity
Select a neighboring publication to make it the new centre.